Pages that link to "Q55445207"
Jump to navigation
Jump to search
The following pages link to Veronika Navrkalova (Q55445207):
Displaying 16 items.
- Recurrent mutations refine prognosis in chronic lymphocytic leukemia. (Q27853022) (← links)
- Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia (Q28303339) (← links)
- Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting (Q35146301) (← links)
- Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification (Q36022313) (← links)
- ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin. (Q36967158) (← links)
- EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. (Q40455172) (← links)
- ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres (Q42384352) (← links)
- Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients (Q42399864) (← links)
- The impact of SF3B1 mutations in CLL on the DNA-damage response (Q44290485) (← links)
- The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells. (Q46603893) (← links)
- Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab. (Q53516167) (← links)
- Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway. (Q54191292) (← links)
- Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia (Q83292194) (← links)
- [Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia] (Q86531735) (← links)
- Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients (Q88018511) (← links)
- Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application (Q112724591) (← links)